These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28276505)

  • 1. Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor.
    Kotani Y; Morito D; Sakata K; Ainuki S; Sugihara M; Hatta T; Iemura SI; Takashima S; Natsume T; Nagata K
    Sci Rep; 2017 Mar; 7():44293. PubMed ID: 28276505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state.
    Morito D; Nishikawa K; Hoseki J; Kitamura A; Kotani Y; Kiso K; Kinjo M; Fujiyoshi Y; Nagata K
    Sci Rep; 2014 Mar; 4():4442. PubMed ID: 24658080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11.
    Vlasschaert C; Xia X; Coulombe J; Gray DA
    BMC Evol Biol; 2015 Oct; 15():230. PubMed ID: 26503449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15.
    Teyra J; Singer AU; Schmitges FW; Jaynes P; Kit Leng Lui S; Polyak MJ; Fodil N; Krieger JR; Tong J; Schwerdtfeger C; Brasher BB; Ceccarelli DFJ; Moffat J; Sicheri F; Moran MF; Gros P; Eichhorn PJA; Lenter M; Boehmelt G; Sidhu SS
    Structure; 2019 Apr; 27(4):590-605.e5. PubMed ID: 30713027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases.
    Chou CK; Chang YT; Korinek M; Chen YT; Yang YT; Leu S; Lin IL; Tang CJ; Chiu CC
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AAA+ ATPase/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets.
    Sugihara M; Morito D; Ainuki S; Hirano Y; Ogino K; Kitamura A; Hirata H; Nagata K
    J Cell Biol; 2019 Mar; 218(3):949-960. PubMed ID: 30705059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent manner.
    Takeda M; Tezuka T; Kim M; Choi J; Oichi Y; Kobayashi H; Harada KH; Mizushima T; Taketani S; Koizumi A; Youssefian S
    Biochem Biophys Res Commun; 2020 May; 525(3):668-674. PubMed ID: 32139119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
    Key J; Maletzko A; Kohli A; Gispert S; Torres-Odio S; Wittig I; Heidler J; Bárcena C; López-Otín C; Lei Y; West AP; Münch C; Auburger G
    Neurogenetics; 2020 Jul; 21(3):187-203. PubMed ID: 32342250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
    Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15.
    Hayes SD; Liu H; MacDonald E; Sanderson CM; Coulson JM; Clague MJ; Urbé S
    J Biol Chem; 2012 Dec; 287(51):43007-18. PubMed ID: 23105109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular structure and function of mysterin/RNF213.
    Morito D
    J Biochem; 2024 Apr; 175(5):495-505. PubMed ID: 38378744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya disease emerging as an immune-related angiopathy.
    Asselman C; Hemelsoet D; Eggermont D; Dermaut B; Impens F
    Trends Mol Med; 2022 Nov; 28(11):939-950. PubMed ID: 36115805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP15 attenuates IGF-I signaling by antagonizing Nedd4-induced IRS-2 ubiquitination.
    Fukushima T; Yoshihara H; Furuta H; Hakuno F; Iemura SI; Natsume T; Nakatsu Y; Kamata H; Asano T; Komada M; Takahashi SI
    Biochem Biophys Res Commun; 2017 Mar; 484(3):522-528. PubMed ID: 28126338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity.
    Fielding AB; Concannon M; Darling S; Rusilowicz-Jones EV; Sacco JJ; Prior IA; Clague MJ; Urbé S; Coulson JM
    Oncogene; 2018 Apr; 37(17):2326-2342. PubMed ID: 29429988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP15 Deubiquitinates CARD9 to Downregulate C-Type Lectin Receptor-Mediated Signaling.
    Xu W; Rush JS; Graham DB; Cao Z; Xavier RJ
    Immunohorizons; 2020 Oct; 4(10):670-678. PubMed ID: 33093067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination.
    Das T; Kim EE; Song EJ
    J Mol Biol; 2019 Sep; 431(19):3900-3912. PubMed ID: 31330151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of the mouse ubiquitin-specific protease Usp15.
    Angelats C; Wang XW; Jermiin LS; Copeland NG; Jenkins NA; Baker RT
    Mamm Genome; 2003 Jan; 14(1):31-46. PubMed ID: 12532266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination.
    Long L; Thelen JP; Furgason M; Haj-Yahya M; Brik A; Cheng D; Peng J; Yao T
    J Biol Chem; 2014 Mar; 289(13):8916-30. PubMed ID: 24526689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection preserves Ubiquitin Specific Protease 4 alternative exon skipping in therian mammals.
    Vlasschaert C; Xia X; Gray DA
    Sci Rep; 2016 Feb; 6():20039. PubMed ID: 26833277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.